Growth Metrics

Biodesix (BDSX) Cash from Investing Activities (2019 - 2026)

Biodesix filings provide 8 years of Cash from Investing Activities readings, the most recent being -$144000.0 for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities fell 5.11% to -$144000.0 in Q1 2026 year-over-year; TTM through Mar 2026 was -$410000.0, a 87.59% increase, with the full-year FY2025 number at -$403000.0, up 88.28% from a year prior.
  • Cash from Investing Activities hit -$144000.0 in Q1 2026 for Biodesix, down from -$104000.0 in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of -$67000.0 in Q3 2025 to a low of -$7.7 million in Q1 2023.
  • Median Cash from Investing Activities over the past 5 years was -$380000.0 (2022), compared with a mean of -$1.8 million.
  • Biggest five-year swings in Cash from Investing Activities: plummeted 2089.2% in 2023 and later surged 96.46% in 2024.
  • Biodesix's Cash from Investing Activities stood at -$2.0 million in 2022, then tumbled by 51.03% to -$3.0 million in 2023, then soared by 70.54% to -$884000.0 in 2024, then soared by 88.24% to -$104000.0 in 2025, then crashed by 38.46% to -$144000.0 in 2026.
  • The last three reported values for Cash from Investing Activities were -$144000.0 (Q1 2026), -$104000.0 (Q4 2025), and -$67000.0 (Q3 2025) per Business Quant data.